Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06281171 · ClinicalTrials.gov registry record · NA
Evaluation of SkillTalk for Autistic Young Adults
A NA study, sponsored by dfusion.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT06281171: Completed NA study, sponsored by dfusion.
NCT06281171 is a NA study that has completed, run by dfusion. The registered enrollment target is 115 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06281171, a NA study, has completed, sponsored by dfusion.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate the effectiveness of using a Microskills video training library for young adults, aged 18-28, with autism spectrum disorder (ASD) to enhance their skills in developing and maintaining healthy relationships. The main questions it aims to answer are: * Does using SkillTalk increase autistic young adults skills in the communications skills that are demonstrated in the video curriculum (skills: resolve conflict, compromise, give feedback)? * Does using SkillTalk increase reported confidence and satisfaction in communication and relationship skills? * Does using SkillTalk increase interpersonal competence? * Does using SkillTalk increase ability to cope with rejection? * Does using SkillTalk improve mental health and wellbeing? Participants will be asked to: * Take a survey at the beginning of the study, after one month the end of the study, and at 3-month follow up * Participate in recorded video calls with projects staff, comprised of 2-3 brief roleplay scenarios of relationship skills at the beginning of the study, after one month the end of the study, and at 3-month follow up * Watch a minimum of 85% of the 60 minutes of video assigned
Primary Outcome
Based on a rubric created for this study of the demonstrable skills for the given recorded roleplay conversation. The points earned on the rubric are summed to create a total score. The scale ranges from 0 to 160 with a higher score indicating higher skill usage.
Interventions
- OTHER SkillTalk for Autistic Young Adults
- OTHER Flyer Library
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2024-08-31 |
| Phase | NA |
What the finished NCT06281171 record still lists
NCT06281171 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which SkillTalk for Autistic Young Adults is the first listed.
NCT06281171 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06281171 about?
NCT06281171 is a clinical study titled "Evaluation of SkillTalk for Autistic Young Adults". The goal of this clinical trial is to evaluate the effectiveness of using a Microskills video training library for young adults, aged 18-28, with autism spectrum disorder (ASD) to enhance their skills in developing and maintaining healthy relationships. The main questions it aims to answer are: * ...
What is the current status of trial NCT06281171?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2024-03-01. Estimated completion is 2024-08-31.
What interventions are being tested in trial NCT06281171?
The interventions under investigation include: SkillTalk for Autistic Young Adults (OTHER), Flyer Library (OTHER).
Who is sponsoring clinical trial NCT06281171?
This trial is sponsored by dfusion, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06281171's enrollment target sits among peer trials
115 810th of 2000 higher than 1,190 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI